CA2403669A1 - Methods and reagents for regulation of cellular responses in biological systems - Google Patents

Methods and reagents for regulation of cellular responses in biological systems Download PDF

Info

Publication number
CA2403669A1
CA2403669A1 CA002403669A CA2403669A CA2403669A1 CA 2403669 A1 CA2403669 A1 CA 2403669A1 CA 002403669 A CA002403669 A CA 002403669A CA 2403669 A CA2403669 A CA 2403669A CA 2403669 A1 CA2403669 A1 CA 2403669A1
Authority
CA
Canada
Prior art keywords
cell
ligand
multivalent
multivalent ligand
sre
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002403669A
Other languages
English (en)
French (fr)
Inventor
Laura L. Kiessling
Laura E. Strong
Jason E. Gestwicki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2403669A1 publication Critical patent/CA2403669A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/178—Lectin superfamily, e.g. selectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Nanotechnology (AREA)
  • Cell Biology (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Composite Materials (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
CA002403669A 2000-03-21 2001-03-21 Methods and reagents for regulation of cellular responses in biological systems Abandoned CA2403669A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19101400P 2000-03-21 2000-03-21
US60/191,014 2000-03-21
PCT/US2001/009174 WO2001071309A2 (en) 2000-03-21 2001-03-21 Methods and reagents for regulation of cellular responses in biological systems

Publications (1)

Publication Number Publication Date
CA2403669A1 true CA2403669A1 (en) 2001-09-27

Family

ID=22703769

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002403669A Abandoned CA2403669A1 (en) 2000-03-21 2001-03-21 Methods and reagents for regulation of cellular responses in biological systems

Country Status (6)

Country Link
US (2) US20030125262A1 (https=)
EP (1) EP1334118A4 (https=)
JP (1) JP2004512258A (https=)
AU (2) AU2001281499B2 (https=)
CA (1) CA2403669A1 (https=)
WO (1) WO2001071309A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248801A1 (en) * 2000-03-21 2004-12-09 Kiessling Laura L. Methods and reagents for regulation of cellular responses in biological systems
JP2004512258A (ja) * 2000-03-21 2004-04-22 ウィスコンシン　アルムニ　リサーチ　ファンデイション 生物系における細胞応答の調節のための方法および試薬
WO2004100997A2 (en) 2003-05-12 2004-11-25 Affymax, Inc. Spacer moiety for poly(ethylene glycol) -modified peptides
JP2007530440A (ja) * 2003-05-12 2007-11-01 アフィーマックス・インコーポレイテッド 新規ポリ（エチレングリコール）修飾化合物およびその用途
SI1625156T1 (sl) * 2003-05-12 2013-02-28 Affymax, Inc. Peptidi, ki se veĹľejo k eritropoetinskemu receptorju
JP4266028B2 (ja) 2003-05-12 2009-05-20 アフィーマックス・インコーポレイテッド エリスロポエチン受容体に結合する新規ペプチド
WO2006062685A2 (en) * 2004-11-11 2006-06-15 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
EA200700990A1 (ru) * 2004-11-11 2008-04-28 Афимакс, Инк. Новые пептиды, которые связывают рецептор эритропоэтина
GB0426822D0 (en) * 2004-12-07 2005-01-12 Precisense As Sensor for detection of glucose
GB0426823D0 (en) * 2004-12-07 2005-01-12 Precisense As Sensor for detection of glucose
US7550433B2 (en) * 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US8324159B2 (en) * 2005-06-03 2012-12-04 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7919461B2 (en) 2005-06-03 2011-04-05 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
JP4742339B2 (ja) * 2005-06-14 2011-08-10 独立行政法人産業技術総合研究所 シアル酸含有３糖化合物、それを用いるサーズウイルスまたはサーズスパイク蛋白質の検出
EP2015784A4 (en) * 2006-05-03 2012-12-26 Wisconsin Alumni Res Found USING RING OPENING METATHESISPOLYMERIZATION SYNTHETIZED MAGNETIC RESONANCE GRAIN
WO2008116293A1 (en) * 2007-03-23 2008-10-02 The Governors Of The University Of Alberta Multivalent heterobifunctional polymers and methods of their use
US9029332B2 (en) 2010-12-15 2015-05-12 The Research Foundation For The State University Of New York Cross-linked peptides and proteins, methods of making same, and uses thereof
US20140350370A1 (en) * 2013-04-08 2014-11-27 The Texas A&M University System Glucose sensing assay
WO2018200951A1 (en) * 2017-04-28 2018-11-01 Tran David T Multi-targeted multi-valent ligand-drug particles for the treatment and prevention of diseases and conditions

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427660A (en) * 1982-03-03 1984-01-24 Research Corporation Formyl-methionyl chemotatic peptide antibiotic conjugates useful in treating infections
US4883851A (en) * 1988-07-25 1989-11-28 California Institute Of Technology Ring opening metathesis polymerization of strained cyclic ethers
US5100972A (en) * 1990-07-16 1992-03-31 General Electric Company Cycloalkene terminated polyarylene ether
US5641622A (en) * 1990-09-13 1997-06-24 Baxter International Inc. Continuous centrifugation process for the separation of biological components from heterogeneous cell populations
US5312940A (en) * 1992-04-03 1994-05-17 California Institute Of Technology Ruthenium and osmium metal carbene complexes for olefin metathesis polymerization
US5710298A (en) * 1992-04-03 1998-01-20 California Institute Of Technology Method of preparing ruthenium and osmium carbene complexes
JP3067031B2 (ja) * 1992-04-03 2000-07-17 カリフォルニア インスティチュート オブ テクノロジー オレフィンメタセシス重合方法
US5599912A (en) * 1993-09-10 1997-02-04 Coretech, Inc. Compounds and methods for suppressing an immune response to sulfomethoxozale containing substances
US5587442A (en) * 1994-12-23 1996-12-24 Kiessling; Laura L. Polyglycomers
US5831108A (en) * 1995-08-03 1998-11-03 California Institute Of Technology High metathesis activity ruthenium and osmium metal carbene complexes
US6060570A (en) * 1996-08-12 2000-05-09 Bp Amoco Corporation Process for preparation of addition products of difunctional telechelic polyolefins from cyclic olefins by olefin metathesis reaction
US6080826A (en) * 1997-01-06 2000-06-27 California Institute Of Technology Template-directed ring-closing metathesis and ring-opening metathesis polymerization of functionalized dienes
US5889128A (en) * 1997-04-11 1999-03-30 Massachusetts Institute Of Technology Living olefin polymerization processes
DE19742980A1 (de) * 1997-09-29 1999-04-01 Espe Dental Ag Dentalmassen auf der Basis von ROMP-Oligomeren oder -Polymeren
US6121236A (en) * 1998-03-24 2000-09-19 The Children's Medical Center Corporation Multivalent ligands which modulate angiogenesis
US6437119B1 (en) * 1998-05-07 2002-08-20 William Lawrence Truett Compounds formed from two or three antibiotics and their processes of preparation
US6280527B1 (en) * 1998-06-12 2001-08-28 International Business Machines Corporation Aqueous quaternary ammonium hydroxide as a screening mask cleaner
US6271315B1 (en) * 1999-06-17 2001-08-07 Wisconsin Alumni Research Foundation Methods for making multivalent arrays
US6291616B1 (en) * 1999-06-17 2001-09-18 Wisconsin Alumni Research Foundation Methods and reagents for capping ruthenium or osmium carbene-catalyzed ROMP products
HUP9902217A3 (en) * 1999-06-29 2002-07-29 Szegoe Peter Polycation based bioconjugates and process for producing thereof
GB9916235D0 (en) * 1999-07-09 1999-09-15 Univ Durham Process for polymerisation of olefins and novel polymerisable olefins
US20040248801A1 (en) * 2000-03-21 2004-12-09 Kiessling Laura L. Methods and reagents for regulation of cellular responses in biological systems
JP2004512258A (ja) * 2000-03-21 2004-04-22 ウィスコンシン　アルムニ　リサーチ　ファンデイション 生物系における細胞応答の調節のための方法および試薬
EP2015784A4 (en) * 2006-05-03 2012-12-26 Wisconsin Alumni Res Found USING RING OPENING METATHESISPOLYMERIZATION SYNTHETIZED MAGNETIC RESONANCE GRAIN

Also Published As

Publication number Publication date
JP2004512258A (ja) 2004-04-22
EP1334118A4 (en) 2005-10-05
US20030125262A1 (en) 2003-07-03
WO2001071309A2 (en) 2001-09-27
AU8149901A (en) 2001-10-03
EP1334118A2 (en) 2003-08-13
AU2001281499B2 (en) 2007-01-04
WO2001071309A3 (en) 2003-05-15
US20070270351A1 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
US20070270351A1 (en) Methods and Reagents for Regulation of Cellular Responses in Biological Systems
US20100104585A1 (en) Methods and Reagents for Regulation of Cellular Responses in Biological Systems
AU2001281499A1 (en) Methods and reagents for regulation of cellular responses in biological systems
JP4467882B2 (ja) ナノ粒子
Kiessling et al. Synthetic multivalent ligands in the exploration of cell-surface interactions
US7741312B2 (en) Compounds and methods for inhibiting selectin-mediated function
US6310043B1 (en) Treatment of bacterial infections
US20090176717A1 (en) Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
US20100151031A1 (en) Discrete size and shape specific organic nanoparticles designed to elicit an immune response
AU2015305108B2 (en) Methods and reagents for prevention and/or treatment of infection
CN1150155A (zh) 抗粘附的哌啶-和吡咯烷羧酸
Zacco et al. A self-assembling peptide scaffold for the multivalent presentation of antigens
WO1998047002A2 (en) Polyvalent presenter combinatorial libraries and their uses
JP2005526692A (ja) 炭水化物ハプテンの免疫原共役体および凝集タンパク質キャリヤ
US9096650B2 (en) Cyclic oligopeptides for binding to a target ligand
Anderluh DC-SIGN antagonists–A paradigm of C-type lectin binding inhibition
US11339502B2 (en) Combinatorial derivatives of oligopeptides having antiviral properties
US20040192601A1 (en) Lipid binding molecules and methods of use
Kun et al. Modern Carbohydrate Microarray Biochip Technologies
Mann Identifying inhibitors of protein-carbohydrate interactions: From novel glycomimetics to polymeric multivalent neoglycoligands
Lamanna Receptor oligomerization in bacterial and neutrophil chemotaxis
Paulowskit Anti-inflammatory regulation of immune cells by membrane active Host Defense Peptides
KIESSLING et al. Departments of Chemistry § and Biochemistry
Martin-Lomas d) Patent Application Publication do Pub. No.: US 2004/0052729 A1
Gestwicki Synthetic multivalent ligands with diverse architectures in the exploration of receptor function: Studies on concanavalin A, the bacterial chemoreceptors, the selectins, and the B cell receptor

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued